Contrast-enhanced Ultrasound in Patients With Crohn´s Disease and Food Allergy
NCT ID: NCT05768971
Last Updated: 2023-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
48 participants
OBSERVATIONAL
2012-12-06
2014-11-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction and Close Monitoring of Postoperative Recurrence by Intestinal Ultrasound After Ileocecal Resection in Crohn's Disease Patients
NCT05713409
Can CT Enteroclysis Predict the Outcome of Crohn's Disease
NCT00572780
Contrast Ultrasound of the Small Intestine in Patients With Crohns Disease
NCT01365767
CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease
NCT01183403
Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Small Bowel Crohn Disease
NCT01671579
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Crohn´s disease
Ultrasound in patients with proven active Crohn´s disease scheduled for therapy with anti tumor necrosis factor alpha antibodies
No interventions assigned to this group
Patients with Food allergy
Patients with proven food allergy
Mild diet
Provocative diet
Healthy controls
Healthy, food-tolerant volunteers without any abdominal complaint
Mild diet
Provocative diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mild diet
Provocative diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Endoscopically and histologically confirmed active Crohn´s disease or
* Previously proven food allergy (double-blind or single-blind food challenge tests with placebo controls previously before the sonographic examination, increased blood and / or intestinal Immunoglobulin E levels, elevated methylhistamine values under provocation and with reproducible reactions during food challenge procedures) or
* Healthy individuals without abdominal complaints
Exclusion Criteria
* Intolerance of the ultrasound contrast agent SonoVue
* Refusal of participation in the study
* Pregnancy or breast-feeding
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Friedrich-Alexander-Universität Erlangen-Nürnberg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dane Wildner
Principal Investigator - Deputy Head of Ultrasound Department, Department of Internal Medicine 1, Universitätsklinikum Erlangen
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dane Wildner, M.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Medicine 1, Divison of ultrasound medicine, University Hospital Erlangen
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DCEUS_CD_NMA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.